No dilution of permission granted to Ikea: Mayaram

The Finance Ministry today said there is no dilution of the permission granted to the Swedish furniture major Ikea to set up its business here, as the Rs 10,500 crore investment proposal is limited to only single brand retailing.

"It is an incorrect understanding of the approval which has been given to Ikea. It's a single brand approval. So they can sell those items which they can brand," Economic Affairs Secretary Arvind Mayaram told reporters here on the sidelines of the Asia Securities Forum meet that concluded here today.

Earlier this week, the Foreign Investment Promotion Board (FIPB) had reportedly halved the product range that Ikea listed out at 30 items. This reportedly excluded items including textiles, office supplies and food, among others.

Swedish furniture major Ikea, which plans to invest Rs 10,500 crore to set up stores in the country, has already received the approval from the Department of Industrial Policy and Promotion (DIPP).

"Whatever they can brand, they have been permitted to," Mayaram said, adding "I think, their core activities have all been permitted."

Meanwhile, Mayaram sought to underplay the bribery allegations against the US retail giant Wal-Mart's domestic joint venture, saying the issue has been blown out of proportion and that the law will take its own course.

"The law takes its own course, and if someone violates the law, a suitable action will accordingly be taken," he said, when asked whether there is a need to take some precautionary steps in the aftermath of the allegations against the world's largest retailer.

Stating that it was not such a big issue, he further said, "the law is in place to deal with such issues."

Wal-Mart Stores Inc has a 50:50 joint venture with the Bharti Group for wholesale business, and runs the operatons under the label of Best Price Modern Wholesale.

... contd.

ALSO READ

Gautam Singhania represents India at Lamborghini Grand Tour

No interim relief to Sterlite Industries over gas leakage: National Green Tribunal

Ranbaxy Laboratories Q1 net profit dips 90% to Rs 126 cr

GlaxoSmithKline Pharma Q1 net profit up 37.52%